Loading clinical trials...

Treatment Clinical Practice in Bipolar Depression in Spain | Clinical Trials | Clareo Health

COMPLETED

Treatment Clinical Practice in Bipolar Depression in Spain

EPIDEP. Epidemiologic Study in Bipolar Depression: Evaluation of the Usual Clinical Practice of Psychiatrists in Spain

NCT00757328•AstraZeneca

Summary

Cross-sectional observational, non interventional, multicenter study of retrospective review of clinical records of ambulatory followed up bipolar patients in order to record epidemiological aspects of the course of the disorder, more specifically of bipolar depression episodes and the clinical practices carried out by psychiatrists in Spain in bipolar depressive episodes

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Diagnosed of Bipolar Disorder I or II (DSM-IV-TR) in ambulatory follow-up
•Evolution of the bipolar diagnoses inferior to 10 years
•Having recorded in the patient's clinical history the clinical management of at least two bipolar depressive episodes

Exclusion Criteria

•Not having enough information recorded in the clinical history for the essential measurement variables
•To have taken part in other study in the last 6 months

Locations (23)

Research Site

Santander, Cantabria, Spain

Research Site

Donostia / San Sebastian, Guipuzcoa, Spain

Research Site

Santiago C., La Coruna, Spain

Research Site

Palma M, Mallorca, Spain

Research Site

Pamplona, Navarre, Spain

Research Site

Oviedo, Principality of Asturias, Spain

Research Site

Bilbao, Vizcaya, Spain

Research Site

Alicante, Spain

Research Site

Almería, Spain

Research Site

Badajoz, Spain

Key Dates

Start Date

July 1, 2008

Completion Date

December 1, 2008

Last Updated

February 18, 2009

Enrollment

378

ACTUAL participants

Conditions

Bipolar Depression

University of Iowa Interventional Psychiatry Service Patient Registry

NCT04480918

Treatment Resistant DepressionMajor Depressive Episode+5 more

View study

RECRUITINGNA

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression

NCT06524505

Bipolar Depression

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 18, 2009Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Treatment Clinical Practice in Bipolar Depression in Spain

Inclusion Criteria

Exclusion Criteria

University of Iowa Interventional Psychiatry Service Patient Registry

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

HD-tDCS for Adolescent Bipolar Depression Targeting S1

Delivering Electronic Cognitive Behavioural Therapy to Patients With Bipolar Disorder and Residual Depressive Symptoms